Dr. Michał Warchoł focuses on the development and applications of computer vision algorithms for accelerating the drug discovery process. Michał joined Ardigen in 2016 to build Data Science and Machine learning capabilities and expertise within Ardigen AI Labs. Currently, Michal is a General Director of the Biomedical Imaging Business Unit that strives to improve both clinical and preclinical stages of the drug discovery process by leveraging information contained in images. Michal did a PhD in Statistics at the Institute of Statistics, Biostatistics and Actuarial Sciences at Université Catholique de Louvain in Belgium. Part of his research program was conducted at the Department of Statistics at Columbia University in New York. Prior to joining Ardigen, Dr. Warchoł co-founded DeepArt UG, a company providing novel image processing algorithms based on deep learning.